Bio-Gene Technology

Bio-Gene Technology EBIT Margin

The EBIT Margin (Operating Margin) of Bio-Gene Technology (BGT.AX) as of Oct 21, 2026 is -721.51 %. In the previous year, EBIT Margin (Operating Margin) was -16,716.50 % — a change of -95.68% (higher).

EBIT Margin

-721.51 %

YoY

-95.68%

Last updated:

EBIT Margin (Operating Margin) of Bio-Gene Technology is 2025 -721.51 % . EBIT Margin (Operating Margin) of Bio-Gene Technology was 2024 -16,716.50 % . It decreases by -95.68% higher compared to the previous year.

For Bio-Gene Technology, the operating (EBIT) margin of -721.5% is up versus -4,149.4% a few years ago.

The Bio-Gene Technology EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-958.28 AUD
Jan 1, 2019
-430.74 AUD
Jan 1, 2020
-238.09 AUD
Jan 1, 2021
-4,149.40 AUD
Jan 1, 2022
-764.50 AUD
Jan 1, 2023
-2,431.01 AUD
Jan 1, 2024
-16,716.50 AUD
Jan 1, 2025
-721.51 AUD
The Bio-Gene Technology EBIT Margin history
YEAREBIT MarginYoY
-721.51 %-95.68%
-16,716.50 %+587.64%
-2,431.01 %+217.99%
-764.50 %-81.58%
-4,149.40 %+1,642.75%
-238.09 %-44.72%
-430.74 %-55.05%
-958.28 %-94.76%
-18,291.80 %+6,600.07%
-273.01 %-98.47%
-17,870.20 %-90.12%
-180,880.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology Ltd develops and commercializes insecticides using beta-triketone platform technology. The company's lead products are Flavocide, a chemically synthesized insecticide based on flavesone, and Qcide, a natural oil product containing tasmanone extracted from Gympie Messmate leaves via steam distillation. These products address insecticide resistance and toxicity issues in crop protection, storage, public health, animal health, and consumer applications. Insecticide manufacturers purchase the company's platform technology and products for commercialization across multiple sectors. The firm's beta-triketone platform provides multiple solutions for insecticide manufacturers seeking to develop novel pest control products. Flavocide and Qcide represent the company's primary commercial offerings, with Flavocide targeting synthetic insecticide markets and Qcide focusing on natural oil-based solutions. The company's technology enables the development of targeted insect control solutions for various applications including agricultural crop protection and public health management. Bio-Gene Technology Ltd. aims to develop a portfolio of targeted insect control solutions for insecticide manufacturers. The company's platform technology allows manufacturers to create new products addressing resistance and toxicity challenges. Through its two lead products, the company provides both synthetic and natural options for the insecticide market, targeting manufacturers who seek innovative solutions for pest management across different industry segments. Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

EBIT Margin (Operating Margin) of Bio-Gene Technology is -721.51 % in 2025.

EBIT Margin (Operating Margin) of Bio-Gene Technology changed from -16,716.50 % to -721.51 %, representing a -95.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bio-Gene Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bio-Gene Technology

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bio-Gene Technology